Director/PDMR Shareholding

RNS Number : 1846H

Primary Health Properties PLC

15 February 2010

 



Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

All relevant boxes should be completed in block capital letters.

1.	Name of the issuer	2.	State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).
	PRIMARY HEALTH PROPERTIES PLC		(I) (II) and (III)
3.	Name of person discharging managerial responsibilities/director	4.	State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
	HARRY HYMAN		PERSONS CONNECTED TO DIRECTOR HARRY HYMAN
5.	Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial interest 1	6.	Description of shares (including class), debentures or derivatives or financial instruments relating to shares
	(I)            PURCHASE BERNARD KELLY (II)           PURCHASE BY TIM WALKER-ARNOTT NON BENEFICIAL INTERESTS OF DIRECTOR BOTH CONNECTED PERSONS  TO HARRY HYMAN		ORDINARY SHARES OF 50 PENCE EACH
7.	Name of registered shareholders(s) and, if more than one, the number of shares held by each of them		State the nature of the transaction
	LLOYDS NOMINEES LIMITED 2,697,660 NEXUS  GROUP HOLDINGS LIMITED 40,332 SMITH & WILLIAMSON NOMINEES LIMITED 5,075 CONTRACTS FOR DIFFERENCE over 869,565 ORDINARY SHARES WITH COMMERZBANK AG BERNARD KELLY   129,396 TIM WALKER-ARNOTT  9,282		(i) ACQUISITION OF 925 ORDINARY SHARES BY BERNARD KELLY (ii) ACQUISITION OF 200 NEW ORDINARY SHARES  IN SCRIP DIVIDEND OFFER
9.	Number of shares, debentures or financial instruments relating to shares acquired	10.	Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A
11.	Number of shares, debentures or financial instruments relating to shares disposed	12.	Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
	N/A		N/A
13.	Price per share or value of transaction	14.	Date and place of transaction
	(i)  279.875 PENCE (II) ONE NEW ORDINARY SHARE FOR APPROX EVERY 32.83 QUALIFYING SHARES HELD ON RECORD DATE		(I) 13 OCTOBER 2009, LONDON (II) 20 NOVEMBER 2009 LONDON
15.	Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)	16.	Date issuer informed of transaction
	48,874  BENEFICIAL 3,751, 310  NON-BENEFICIAL 3,799,784 TOTAL  6.18 %		15 FEBRUARY  2010

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

17.	Date of grant	18.	Period during which or date on which exercisable
19.	Total amount paid (if any) for grant of the option	20.	Description of shares or debentures involved (class and number)
21.	Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise	22.	Total number of shares or debentures over which options held following notification
23.	Any additional information	24.	Name of contact and telephone number for queries RACHEL BUTLIN, COMPANY SECRETARY, J O HAMBRO CAPITAL MANAGEMENT LIMITED 0207 747 5680
Name of authorised official of issuer responsible for making notification FOR AND ON BEHALF OF J O HAMBRO CAPITAL MANAGEMENT LIMITED AS COMPANY SECRETARY OF PRIMARY HEALTH PROPERTIES PLC RACHEL BUTLIN, COMPANY SECRETARY Date of notification  15 FEBRUARY  2010

Notes:    This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

(1)	An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2)	An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3)	An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4)	An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

END

 

 

RDSBCGDDRSBBGGU